October 1, 2024
Over the past year, the CDCB Board of Directors and staff have been focused on developing and then executing the new strategic plan that will guide our future initiatives and priorities. I’m pleased to share more about this plan with you.
October 13, 2022
Jay Weiker, Chair of the CDCB Board of Directors, shares the CDCB progress and priorities of the past year in the newly-published 2022 Activity Report.
A monthly newsletter, details genetic evaluation updates and industry news.